AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
09.09.20	AstraZeneca halts Late-stage COVID-19 Vaccine Trial After U.K. Participant Falls Ill (RTTNews)
01.09.20	Astrazeneca Covid-19 Vaccine Candidate Enters Late-stage Study In US (RTTNews)
01.09.20	Oxford Biomedica Expands Supply Deal With AstraZeneca For COVID-19 Vaccine Candidate, AZD1222 (RTTNews)
01.09.20	AstraZeneca Reports Positive Phase III DAPA-CKD Trial Results With Farxiga (RTTNews)
01.09.20	AstraZeneca: EU Approves Imfinzi To Treat Extensive-stage Small Cell Lung Cancer (RTTNews)
25.08.20	AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 - Quick Facts (RTTNews)
24.08.20	Trump Mulls Fast-tracking AstraZeneca Covid-19 Vaccine Before Election: Report (RTTNews)
21.08.20	AstraZeneca's Imfinzi Gets Approval In Japan For Extensive-stage Small Cell Lung Cancer (RTTNews)
19.08.20	Australia To Be Among The First To Receive COVID-19 Vaccine From AstraZeneca (RTTNews)
18.08.20	Premier Announces Hyperkalemia Discharge Protocol To Reduce Readmissions To Hospitals (RTTNews)
18.08.20	AstraZeneca: FDA To Review Imfinzi For New Less-frequent Dosing Option (RTTNews)
13.08.20	AstraZeneca Makes First Shipment Of Flumist Quadrivalent Vaccine In U.S. (RTTNews)
12.08.20	U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine (RTTNews)
04.08.20	AstraZeneca Prices $3 Bln Bond Offering (RTTNews)
30.07.20	AstraZeneca Q2 Profit Surges; Backs 2020 Outlook (RTTNews)
28.07.20	AstraZeneca Says Farxiga Meets All Primary, Secondary Endpoints In Phase III DAPA-CKD Trial (RTTNews)
27.07.20	Emergent Agrees With AstraZeneca To Deploy CDMO Services For COVID-19 Vaccine Candidate (RTTNews)
27.07.20	AstraZeneca's Calquence Receives Positive CHMP Opinion For Chronic Blood Cancer (RTTNews)
27.07.20	AstraZeneca In Deal To Develop, Commercialise Daiichi Sankyo's DS-1062 For Upfront Payment Of $1 Bln (RTTNews)
24.07.20	AstraZeneca : FDA Approves Breztri Aerosphere For Maintenance Treatment Of COPS (RTTNews)
21.07.20	AZN's COVID-19 Vaccine Shows Strong Responses, ACAD Fails CLARITY Study, BTAI Hits New High (RTTNews)
20.07.20	AstraZeneca's COVID-19 Vaccine Shows Promising Response (RTTNews)
20.07.20	AstraZeneca's Interim Trials Show COVID-19 Vaccine Safe, Induces Immune Reaction (RTTNews)
20.07.20	Pre-market Movers In Healthcare Sector: TNXP, IBIO, VCNX, AZN, APDN... (RTTNews)
19.07.20	Clinical Trial Readouts Of COVID-19 Vaccines, Drugs Due In July (RTTNews)
16.07.20	AstraZeneca's FARXIGA Granted Fast Track Designation In U.S. For Heart Failure (RTTNews)
16.07.20	AstraZeneca: BRILINTA Significantly Reduced Rate Of Composite Of Stroke And Death In Trial (RTTNews)
15.07.20	AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch (RTTNews)
14.07.20	IQVIA, AstraZeneca Join To Accelerate Development Of Potential COVID-19 Vaccine (RTTNews)
09.07.20	AstraZeneca: FDA Accepts SNDA, Granted Priority Review For Brilinta To Treat Stroke (RTTNews)
08.07.20	AstraZeneca: Lynparza Gets EU Approval For BRCA-mutated Metastatic Pancreatic Cancer (RTTNews)
22.06.20	Ascentage Collaborates With Acerta To Evaluate Combination Of Bcl-2 And BTK Inhibitors (RTTNews)
17.06.20	AstraZeneca's Potential Vaccine Likely To Protect Against Covid-19 For A Year : Report (RTTNews)
15.06.20	Catalent Signs Deal With AstraZeneca To Manufacture COVID-19 Vaccine Candidate (RTTNews)
13.06.20	AstraZeneca Inks Contract With Europe's IVA To Supply 400 Mln Doses Of COVID-19 Vaccine (RTTNews)
13.06.20	Race For COVID-19 Vaccine: Who Are The Key Players? (RTTNews)
06.06.20	The Week That Was In COVID: Russia Approves 1st COVID-19 Drug, INO Sues Vaccine Supplier... (RTTNews)
04.06.20	List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION (RTTNews)
01.06.20	FDA Approve AstraZeneca's Brilinta To Reduce Risk Of Stroke In High-risk Patients With CAD (RTTNews)
01.06.20	AstraZeneca: Lynparza Recommended For Marketing Authorisation In EU (RTTNews)
30.05.20	The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA (RTTNews)
29.05.20	AstraZeneca: IMFINZI Plus Tremelimumab Showed Promising Clinical Activity In HCC Patients (RTTNews)
29.05.20	AstraZeneca Announces Results Of Updated Analysis Of Phase III CASPIAN Trial (RTTNews)
29.05.20	AstraZeneca : Phase II DESTINY-CRC01 Trial Shows Clinically Meaningful Activity In Colorectal Cancer (RTTNews)
29.05.20	AstraZeneca: ADAURA Trial With Tagrisso Shows Improvement In Disease-free Survival (RTTNews)
28.05.20	Oxford Biomedica Signs Deal With AstraZeneca For Manufacture Of COVID-19 Vaccine Candidate (RTTNews)
22.05.20	AstraZeneca: FDA Grants Orphan Drug Designation To Enhertu For Gastric Cancer (RTTNews)
21.05.20	AstraZeneca Receives $1 Bln From U.S. To Produce Oxford's Covid-19 Vaccine (RTTNews)
20.05.20	FDA OKs Myriad's BRACAnalysis CDx Test As Companion Diagnostics For Lynparza (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

24.12.24		Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge
24.12.24		Börse New York in Grün: NASDAQ 100 steigt nachmittags
24.12.24		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
23.12.24		AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform
18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

24.12.24

Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge

24.12.24

Börse New York in Grün: NASDAQ 100 steigt nachmittags

24.12.24

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

23.12.24

AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu AstraZeneca PLC (spons. ADRs)

Aktien Top/Flop

AstraZeneca Peer Group Nachrichten

Meistgelesene Nachrichten